Showing results (81-90 of 125) with videos related to
Sort By:
Pageof 13
Journal of Substance Use|July 18, 2024
Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use DisorderChristina A Brezing, Mohammad Sibai, C Jean Choi, et al.Addictive Behaviors|October 25, 2016
Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trialAnnie Lévesque, Aimee N C Campbell, Martina Pavlicova, et al.The Annals of Thoracic Surgery|May 27, 2020
Assessment of Anomalous Coronary Arteries by Imagers and Surgeons: Comparison of Imaging ModalitiesKanwal M Farooqi, Shannon N Nees, Jennifer Smerling, et al.Journal of Addiction Medicine|October 3, 2023
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use DisorderMatisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.Drug and Alcohol Dependence|May 23, 2022
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexoneJudith I Tsui, Aimee N C Campbell, Martina Pavlicova, et al.Substance Use & Misuse|April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT TrialKenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.Drug and Alcohol Dependence Reports|February 27, 2023
Intranasal oxytocin may improve odds of abstinence in cocaine-dependent patients: results from a preliminary studyWilfrid Noël Raby, Matthew Heller, Demetrios Milliaressis, et al.Focus (American Psychiatric Publishing)|January 31, 2020
Long-Term Efficacy of Repeated Daily Prefrontal Transcranial Magnetic Stimulation (TMS) In Treatmnt-Resistant DepressionAntonio Mantovani, Martina Pavlicova, David Avery, et al.BMC Health Services Research|August 4, 2016
Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance usersAimee N C Campbell, Don Des Jarlais, Cooper Hannah, et al.Drug and Alcohol Dependence|November 10, 2019
Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxoneLesia M Ruglass, Jennifer Scodes, Martina Pavlicova, et al.Pageof 13